Association between Obesity, Race or Ethnicity, and Luminal Subtypes of Breast Cancer
- PMID: 36428500
- PMCID: PMC9687751
- DOI: 10.3390/biomedicines10112931
Association between Obesity, Race or Ethnicity, and Luminal Subtypes of Breast Cancer
Abstract
Luminal breast cancers are the most common genomic subtype of breast cancers where Luminal A cancers have a better prognosis than Luminal B. Exposure to sex steroids and inflammatory status due to obesity are key contributors of Luminal tumor development. In this study, 1928 patients with Luminal A breast cancer and 1610 patients with Luminal B breast cancer were compared based on body mass index (BMI), age, race, menopausal status, and expressed receptors (i.e., estrogen (ER), progesterone (PR), and human epidermal growth factor receptor 2 (HER2)). Patients with Luminal B tumors had a significantly higher mean BMI (Δ = 0.69 kgm−2 [0.17, 1.21], p = 0.010) versus Luminal A. Interestingly, the risks of Luminal B tumors were higher among Black/African American patients versus White and Hispanic patients (p < 0.001 and p = 0.001, respectively). When controlled for each other, Black/African American race (p < 0.001) and increased BMI (p = 0.008) were associated with increased risks of Luminal B carcinoma, while postmenopausal status was associated with a decreased risk (p = 0.028). Increased BMI partially mediated the strong association between Black/African American race and the risk of Luminal B carcinoma. Thus, Black/African American race along with obesity seem to be associated with an increased risk of more aggressive Luminal B breast carcinomas.
Keywords: Luminal A; Luminal B; breast cancer; obesity; race.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Makki J., Myint O., Wynn A.A., Samsudin A.T., Daisy Vanitha J. Expression distribution of cancer stem cells, epithelial to mesenchymal transition, and telomerase activity in breast cancer and their association with clinicopathologic characteristics. Clin. Med. Insights: Pathol. 2015;8:CPath-S19615. doi: 10.4137/CPath.S19615. - DOI - PMC - PubMed
-
- Neuhouser M.L., Aragaki A.K., Prentice R.L., Manson J.E., Chlebowski R., Carty C.L., Ochs-Balcom H.M., Thomson C.A., Caan B.J., Tinker L.F. Overweight, obesity, and postmenopausal invasive breast cancer risk: A secondary analysis of the women’s health initiative randomized clinical trials. JAMA Oncol. 2015;1:611–621. doi: 10.1001/jamaoncol.2015.1546. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
